MRSA Research - Methicillin-Resistant Staphylococcus Aureus, Hospitals, Infection, Antibiotic Resistance, Superbugs

MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.


MRSA Research Today

Home

View Latest Issue

Information About MRSA

Books on MRSA

Advertising in Research Today

View Other Research Today Publications



Volume 5 (2008), Issue 9 (September)

  1. Community-Acquired Methicillin-Resistant Staphylococcus aureus Emerging as an Important Cause of Necrotizing Fasciitis.
    Surg Infect (Larchmt), 9(4): 469-74. [Abstract] [Full-text]
  2. Characterization of the pTZ2162 encoding multidrug efflux gene qacB from Staphylococcus aureus.
    Plasmid, 60(2): 108-17. [Abstract] [Full-text]
  3. A computational model of antibiotic-resistance mechanisms in methicillin-resistant Staphylococcus aureus (MRSA).
    J Theor Biol, 254(2): 284-93. [Abstract] [Full-text]
  4. In Vivo and In Vitro Antibacterial Efficacy of PDS Plus (Polidioxanone with Triclosan) Suture.
    Surg Infect (Larchmt), 9(4): 451-7. [Abstract] [Full-text]
  5. Efflux genes and active efflux activity detection in Malaysian clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    J Basic Microbiol, 48(4): 245-51. [Abstract] [Full-text]
  6. Reduction in Rates of Methicillin-Resistant Staphylococcus aureus Infection after Introduction of Quarterly Linezolid-Vancomycin Cycling in a Surgical Intensive Care Unit.
    Surg Infect (Larchmt), 9(4): 423-31. [Abstract] [Full-text]
  7. Simultaneous presence of an invasive and a carrier strain of methicillin-resistant Staphylococcus aureus (MRSA) in a family.
    Scand J Infect Dis. [Abstract] [Full-text]
  8. Synergistic antibacterial effect between silybin and N,N'-dicyclohexylcarbodiimide in clinical Pseudomonas aeruginosa isolates.
    J Microbiol, 46(4): 462-7. [Abstract] [Full-text]
  9. Methicillin-resistant Staphylococcus aureus as a common cause of vulvar abscesses.
    Obstet Gynecol, 112(3): 538-44. [Abstract] [Full-text]
  10. Community-acquired methicillin-resistant Staphylococcus aureus among patients with puerperal mastitis requiring hospitalization.
    Obstet Gynecol, 112(3): 533-7. [Abstract] [Full-text]
  11. Staphylococcus aureus bacteraemia of unknown primary source: Where do we stand?
    Int J Antimicrob Agents. [Abstract] [Full-text]
  12. The epidemiology of antibiotic resistance.
    Int J Antimicrob Agents. [Abstract] [Full-text]
  13. Lysostaphin: an antistaphylococcal agent.
    Appl Microbiol Biotechnol, 80(4): 555-61. [Abstract] [Full-text]
  14. Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347.
    J Am Chem Soc, 130(36): 12102-10. [Abstract] [Full-text]
  15. Changing patterns in frequency of recovery of five methicillin-resistant Staphylococcus aureus clones in portuguese hospitals: surveillance over a 16-year period.
    J Clin Microbiol, 46(9): 2912-7. [Abstract] [Full-text]
  16. Countrywide molecular survey of methicillin-resistant Staphylococcus aureus strains in Poland.
    J Clin Microbiol, 46(9): 2930-7. [Abstract] [Full-text]
  17. MVPlex assay for direct detection of methicillin-resistant Staphylococcus aureus in Naris and other swab specimens.
    J Clin Microbiol, 46(9): 3107-9. [Abstract] [Full-text]
  18. Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients.
    J Clin Microbiol, 46(9): 2890-6. [Abstract] [Full-text]
  19. Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004.
    J Clin Microbiol, 46(9): 2837-41. [Abstract] [Full-text]
  20. Inactivating Methicillin Resistant Staphylococcus aureus (MRSA) and Other Pathogens by Bacteriocins OR-7 and E 50-52.
    J Clin Microbiol. [Abstract] [Full-text]
  21. Modified vancomycin dosing protocol for treatment of diabetic foot infections.
    Am J Health Syst Pharm, 65(18): 1740-3. [Abstract] [Full-text]
  22. Outcome of patients with meticillin-resistant Staphylococcus aureus bacteraemia at an Emergency Department of a medical centre in Taiwan.
    Int J Antimicrob Agents, 32(4): 326-32. [Abstract] [Full-text]
  23. MRSA carriage in healthcare personnel in contact with farm animals.
    J Hosp Infect, 70(2): 186-90. [Abstract] [Full-text]
  24. Results of a multicentre randomised controlled trial of statistical process control charts and structured diagnostic tools to reduce ward-acquired meticillin-resistant Staphylococcus aureus: the CHART Project.
    J Hosp Infect, 70(2): 127-35. [Abstract] [Full-text]
  25. Investigation of Panton-Valentine leukocidin genes and SCCmec types in clinical Staphylococcus aureus isolates from Turkey.
    Microb Drug Resist, 14(3): 203-10. [Abstract] [Full-text]
  26. Staphylococcal cassette chromosome mec (SCCmec) analysis and antimicrobial susceptibility patterns of methicillin-resistant Staphylococcus aureus (MRSA) isolates in Tehran, Iran.
    Microb Drug Resist, 14(3): 217-20. [Abstract] [Full-text]
  27. Mucroporin, the first cationic host defence peptide from the venom of Lychas mucronatus.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  28. Emergence of the USA300 strain of methicillin-resistant Staphylococcus aureus in a burn-trauma unit.
    J Burn Care Res, 29(5): 790-7. [Abstract] [Full-text]
  29. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients.
    Burns, 34(7): 1033-6. [Abstract] [Full-text]
  30. Outbreak of invasive methicillin-resistant Staphylococcus aureus infection associated with acupuncture and joint injection.
    Infect Control Hosp Epidemiol, 29(9): 859-65. [Abstract] [Full-text]
  31. Poor functional status as a risk factor for surgical site infection due to methicillin-resistant Staphylococcus aureus.
    Infect Control Hosp Epidemiol, 29(9): 832-9. [Abstract] [Full-text]
  32. New antimicrobial drug resistance and epidemiological typing patterns of Staphylococci from clinical isolates and raw meats.
    Arch Pharm Res, 31(8): 1016-22. [Abstract] [Full-text]
  33. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis.
    PLoS ONE, 3(9): e3198. [Abstract] [Full-text]
  34. Infection control and meticillin-resistant Staphylococcus aureus in nursing homes in Oslo.
    J Hosp Infect. [Abstract] [Full-text]
  35. Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility.
    Am J Infect Control, 36(7): 468-71. [Abstract] [Full-text]
  36. Risk factors for methicillin-resistant Staphylococcus aureus surgical site infection.
    Infect Control Hosp Epidemiol, 29(9): 890-3. [Abstract] [Full-text]
  37. LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococci.
    FEMS Microbiol Lett, 287(1): 22-33. [Abstract] [Full-text]
  38. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    FEMS Microbiol Lett, 287(2): 185-91. [Abstract] [Full-text]
  39. Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia due to a linezolid "tolerant" strain.
    Heart Lung, 37(5): 398-400. [Abstract] [Full-text]
  40. A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
    Int J Clin Pract, 62(9): 1455-64. [Abstract] [Full-text]
  41. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
    J Antimicrob Chemother, 62(4): 773-5. [Abstract] [Full-text]
  42. Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus.
    Proc Natl Acad Sci U S A, 105(37): 14130-5. [Abstract] [Full-text]
  43. Contribution of acquired meticillin-resistant Staphylococcus aureus bacteraemia to overall mortality in a general intensive care unit.
    J Hosp Infect. [Abstract] [Full-text]
  44. Public transport as a reservoir of methicillin-resistant staphylococci.
    Lett Appl Microbiol. [Abstract] [Full-text]
  45. In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China.
    Diagn Microbiol Infect Dis, 62(2): 226-9. [Abstract] [Full-text]
  46. Antimicrobial activity of some sulfonamide derivatives on clinical isolates of Staphylococus aureus.
    Ann Clin Microbiol Antimicrob, 7: 17. [Abstract] [Full-text]
  47. Molecular epidemiology and antimicrobial susceptibilities of 273 exfoliative toxin-encoding-gene-positive Staphylococcus aureus isolates from patients with impetigo in Japan.
    J Med Microbiol, 57: 1251-8. [Abstract] [Full-text]
  48. Clinical utility of infection control documentation of prior methicillin-resistant Staphylococcus aureus colonization or infection for optimization of empirical antibiotic therapy.
    Infect Control Hosp Epidemiol, 29(10): 972-4. [Abstract] [Full-text]
  49. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease.
    J Infect Dis, 198(8): 1166-70. [Abstract] [Full-text]
  50. Osteo-odonto-keratoprosthesis in Japan.
    Cornea, 27: S56-61. [Abstract] [Full-text]
  51. Methicillin-resistant Staphylococcus aureus endophthalmitis after phacoemulsification in a continuous ambulatory peritoneal dialysis patient.
    J Cataract Refract Surg, 34(10): 1806-8. [Abstract] [Full-text]
  52. Evaluation of the risks of shedding Salmonellae and other potential pathogens by therapy dogs fed raw diets in Ontario and Alberta.
    Zoonoses Public Health, 55(8): 470-80. [Abstract] [Full-text]
  53. Acquired vancomycin resistance in clinically relevant pathogens.
    Future Microbiol, 3: 547-62. [Abstract] [Full-text]
  54. Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus.
    Antimicrob Agents Chemother, 52(10): 3755-62. [Abstract] [Full-text]
  55. In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models.
    Antimicrob Agents Chemother, 52(10): 3492-6. [Abstract] [Full-text]
  56. Novel type of staphylococcal cassette chromosome mec in a methicillin-resistant Staphylococcus aureus strain isolated in Sweden.
    Antimicrob Agents Chemother, 52(10): 3512-6. [Abstract] [Full-text]
  57. The use of Gene Ontology terms for predicting highly-connected 'hub' nodes in protein-protein interaction networks.
    BMC Syst Biol, 2: 80. [Abstract] [Full-text]
  58. Bed occupancy and incidence of Methicillin-resistant Staphylococcus aureus infection in an intensive care unit.
    Anaesthesia, 63(10): 1070-3. [Abstract] [Full-text]
  59. Monitoring environmental cleanliness on two surgical wards.
    Int J Environ Health Res, 18(5): 357-64. [Abstract] [Full-text]
  60. Staphylococci in primary skin and soft tissue infections in a Swedish county.
    Scand J Infect Dis. [Abstract] [Full-text]
  61. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06.
    J Antimicrob Chemother, 62: ii65-74. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2012 MRSA Research Today. All Rights Reserved.



MRSA Research Today Archive:

Volume 1 (2004)
  Issue 1 (October)
  Issue 2 (November)
  Issue 3 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



MRSA Books

The ''hospital superbug'': Social representations of MRSA [An article from: Social Science & Medicine]

The ''hospital superbug'': Social representations of MRSA [An article from: Social Science & Medicine]